Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease

Journal of Leukocyte Biology

Volumn 72, Issue 4, 2002, Pages 628-635

  Cui, Youhong ^a,b   Le, Yingying ^b   Yazawa, Hiroshi ^b   Gong, Wanghua ^b   Wang, Ji Ming ^b  

^a Lanzhou Military Medical College   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Central nervous system; Macrophage; Microglia; NSAID

Indexed keywords

AMYLOID BETA PROTEIN; FORMYLPEPTIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; ANIMAL CELL; CELL COMPARTMENTALIZATION; CENTRAL NERVOUS SYSTEM; COMPLEX FORMATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MICROGLIA; MONONUCLEAR PHAGOCYTE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; SENILE PLAQUE; TARGET CELL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; MICROGLIA; PEPTIDE FRAGMENTS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOXIN; RECEPTORS, PEPTIDE;

ANIMALIA;

EID: 0036826850     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Snyderman, R., Uhing, R. J. (1992) Chemoattractant stimulus-response coupling. In Inflammation: Basic Principles and Clinical Correlates (J. I. Gallin, I. M. Goldstein, R. Snyderman, eds.), New York, NY, Raven, 421-439.
2. Goldstein, I. M. (1992) Complement: biologically active products. In Inflammation: Basic Principles and Clinical Correlates (J. I. Gallin, I. M. Goldstein, R. Snyderman, eds.), New York, NY, Raven, 55-74.
3. Rollins, B. J. (1997) Chemokines. Blood 90, 909-928.
4. Le, Y., Gong, W., Shen, W., Li, B., Dunlop, N. M., Wang, J. M. (2000) A burgeoning family of biological mediators: chemokines and chemokine receptors. Arch. Immunol. Ther. Exp. (Warsz) 48, 143-150.
5. Murphy, P. M. (1996) The N-formyl peptide chemotactic receptors. In Chemoattractant Ligands and Their Receptors (R. Horuk, ed.), Boca Raton, FL, CRC, 269-299.
6. Prossnitz, E. R., Ye, R. D. (1997) The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74, 73-102.
7. Le, Y., Li, B., Gong, W., Shen, W., Hu, J., Dunlop, N. M., Oppenheim, J. J., Wang, J. M. (2000) Novel pathophysiological role of classical chemotactic peptide receptors and their communications with chemokine receptors. Immunol. Rev. 177, 185-194.
8. Liang, T. S., Wang, J. M., Murphy, P. M., Gao, J. L. (2000) Serum amyloid A is a chemotactic agonist at FPR2, a low affinity N-formylpeptide receptor on mouse neutrophils. Biochem. Biophys. Res. Commun. 270, 331-335.
9. Hartt, J. K., Liang, T., Sahagun-Ruiz, A., Wang, J. M., Gao, J. L., Murphy, P. M. (2000) The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptor. Biochem. Biophys. Res. Commun. 272, 699-704.
10. Gao, J. L., Lee, E. L., Murphy, P. M. (1999) Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189, 657-662.
11. Su, S. B., Gong, W., Gao, J. L., Shen, W., Murphy, P.M., Oppenheim, J. J., Wang, J. M. (1999) A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189, 395-402.
12. Le, Y., Gong, W., Tiffany, H. L., Tumanov, A., Nedospasov, S., Shen, W., Dunlop, N. M., Gao, J. L., Murphy, P. M., Oppenheim, J. J., Wang, J. M. (2001) Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21, RC123.
13. Le, Y., Yazawa, H., Gong, W., Yu, Z., Ferrans, V. J., Murphy, P. M., Wang, J. M. (2001) Cutting edge: the neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J Immunol. 166, 1448-1451.
14. Glenner, G. G. (1980) Amyloid deposits and amyloidsis. N. Engl. J. Med. 302, 1283-1292.
15. Stone, M. J. (1990) Amyloidosis: a final common pathway for protein deposition in tissues. Blood 75, 531-545.
16. Selkoe, D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 (6738 Suppl.), A23-A31.
17. Rogers, J. (1995) Inflammation as a pathogenic mechanism in Alzheimer's disease. Arzneim.-Forsch. 45, 439-442.
18. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M., Fiebich, B. L., Finch, C. E., Frautschy, S., Griffin, W. S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I. R., McGeer, P. L., O'Banion, M. K., Pachter, J., Pasinetti, G., Plata-Salaman, C., Rogers, J., Rydel, R., Shen, Y., Streit, W., Strohmeyer, R., Tooyoma, I., Van Muiswinkel, F. L., Veerhuis, R., Walker, D., Webster, S., Wegrzyniak, B., Wenk, G., WyssCoray, T. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 183-421.
19. Nakai, M., Hojo, K., Taniguchi, T., Terashima, A., Kawamata, T., Hashimoto, T., Maeda, K., Tanaka, C. (1998) PKC and tyrosine kinase involvement in amyloid beta (25-35)-induced chemotaxis of microglia. Neuroreport 9, 3467-3470.
20. Kopec, K. K., Carroll, R. T. (1998) Alzheimer's beta-amyloid peptide 1-42 induces a phagocytic response in murine microglia. J. Neurochem. 71, 2123-2131.
21. Bonaiuto, C., McDonald, P. P., Rossi, F., Cassatella, M. A. (1997) Activation of nuclear factor-kappa B by beta-amyloid peptides and interferongamma in murine microglia. J. Neuroimmunol. 77, 51-56.
22. McDonald, D. R., Brunden, K. R., Landreth, G. E. (1997) Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17, 2284-2294.
23. McGeer, P. L., McGeer, E., Rogers, J., Sibley, J. (1991) Antiinflammatory drugs and Alzheimer's disease. Lancet 335, 1037.
24. Stewart, W. F., Kawas, C., Corrada, M., Metter, E. J. (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626-632.
25. Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., MeGeer, P. L., Kaszniak, A. W. (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43, 1609-1611.
26. Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C., Brandt, J. (1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45, 51-55.
27. Mackenzie, I. R., Munoz, D. G. (1998) Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50, 986-990.
28. Dzenko, K. A., Weltzien, R. B., Pachter, J. S. (1997) Suppression of A beta-induced monocyte neurotoxicity by antiinflammatory compounds. J. Neuroimmunol. 80, 6-12.
29. Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., Tran, T., Ubeda, O., Ashe, K. H., Frautschy, S. A., Cole, G. M. (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20, 5709-5714.
30. Mudher, A., Lovesto, S. (2002) Alzheimer's disease-do tauists and baptidts finally shake hands? Trends Neurosci. 25, 22-26.
31. El Khoury, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., Loike, J. D. (1996) Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382, 716-719.
32. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stem, D., Schmidt, A. M. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
33. Lorton, D. (1997) Beta-amyloid-induced IL-1 beta release from an activated human monocyte cell line is calcium- and G-protein-dependent. Mech. Ageing Dev. 94, 199-211.
34. Lorton, D., Schaller, J., Lala, A., De Nardin, E. (2000) Chemotactic-like receptors and Abeta peptide induced responses in Alzheimer's disease. Neurobiol. Aging 21, 463-473.
35. Tiffany, H. L., Lavigne, M. C., Cui, Y. H., Wang, J. M., Leto, T. L., Gao, J. L., Murphy, P. M. (2001) Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J. Biol. Chem, 276, 23645-23652.
36. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383.
37. Perry, V. H., Bolton, S. J., Anthony, D. C., Betmouni, S. (1998) The contribution of inflammation to acute and chronic neurodegeneration. Res. Immunol. 149, 721-725.
38. Brown, D. R., Kretzschmar, H. A. (1997) Microglia and prion disease: a review. Histol. Histopathol. 12, 883-892.
39. Peyrin, J. M., Lasmezas, C. I., Haik, S., Tagliavini, F., Salmona, M., Williams, A., Richie, D., Deslys, J. P., Dormont, D. (1999) Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 10, 723-729.
40. Silei, V., Fabrizi, C., Venturini, G., Salmona, M., Bugiani, O., Tagliavini, F., Lauro, G. M. (1999) Activation of microglial cells by PrP and betaamyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels. Brain Res. 818, 168-170.
41. 2+ in microglia activated by prion protein fragment. Glia 21, 253-257.
42. Combs, C. K., Johnson, D. E., Cannady, S, B., Lehman, T. M., Landreth, G. E. (1999) Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of betaamyloid and prion proteins. J. Neurosci. 19, 928-939.
43. Leuba, G., Saini, K., Savioz, A., Charnay, Y. (2000) Early-onset familial Alzheimer disease with coexisting β-amyloid and prion pathology. J. Am. Med. Assoc. 283, 1689-1691.
44. Streit, W. J., Walter, S.A., Pennell, N. A. (1999) Reaction microgliosis. Prog. Neurobiol. 57, 563-581.
45. Kreutzberg, G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
46. Nolte, C., Möller, T., Walter, T., Kettenmann, H. (1996) Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton. Neuroscience 73, 1091-1107.
47. Tanabe, S., Heesen, M., Yoshizawa, I., Berman, M. A., Luo, Y., Bleul, C. C., Springer, T. A., Okuda, K., Gerard, N., Dorf, M. E. (1997) Functional expression of CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J. Immunol. 159, 905-911.
48. Boddeke, E. W. G. M., Meigel, I., Frentzel, S., Gourmala, N. G., Harrison, J. K., Buttini, M., Spleiss, O., Gebicke-Harter, P. (1999) Cultured rat microglia express functional β-chemokine receptors. J. Neuroimmunol. 98, 176-184.
49. Yao, J., Harvath, L., Gilbert, D. L., Colton, C. A. (1990) Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27, 36-42.
50. Lacy, M., Jones, J., Whittemore, S. R., Haviland, D. L., Wetsel, R. A., Barnum, S. R. (1995) Expression of the receptor for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J. Neuroimmunol. 61, 71-78.
51. Muller-Ladner, U., Jones, J. L., Wetsel, R. A., Gay, S., Raine, C. S., Barnum, S. R. (1996) Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J. Neurol. Sci. 144, 135-141.
52. Cui, Y. H., Le, Y., Gong, W., Proost, P., Van Damme, J., Murphy, W. J., Wang, J. M. (2002) Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J. Immunol. 168, 434-442.
53. Ulevitch, R. J., Tobias, P. S. (1999) Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11, 19-22.
54. Sica, A., Saccani, A., Borsatti, A., Power, C. A., Wells, T. N. C., Luini, W., Polentarutti, N., Sozzani, S., Mantovani, A. (1997) Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 185, 969-974.
55. Franchin, G., Zybarth, G., Dai, W. W., Dubrovsky, L., Reiling, N., Schmidtmayerova, H., Bukrinsky, M., Sherry, B. (2000) Lipopolysaccharide inhibits HIV-1 infection of monocyte-derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J. Immunol. 164, 2592-2601.
56. Zhou, Y., Yang, Y., Warr, G., Bravo, R. (1999) LPS down-regulates the expression of chemokine receptor CCR2 in mice and abolishes macrophage infiltration in acute inflammation. J. Leukoc. Biol. 65, 265-269.
57. Sozzani, S., Allavena, P., Amico, G. D., Luini, W., Bianchi, G., Kataura, M., Imai, T., Yoshie, O., Bonecchi, R., Mantovani, A. (1998) Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161, 1083-1086.
58. Penton-Rol, G., Polentarutti, N., Luini, W., Borsatti, A., Mancinelli, R., Sica, A., Sozzani, S., Mantovani, A. (1998) Selective inhibition of the chemokine receptor CCR2 in human monocytes by IFN-γ. J. Immunol. 160, 3869-3873.
59. Khandaker, M, H., Mitchell, G., Xu, L., Andrews, J. D., Singh, R., Leung, H., Madrenas, J., Ferguson, S. S. G., Feldman, R. D., Kelvin, D. J. (1999) Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-α-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 93, 2173-2185.
60. Lloyd, A. R., Biragyn, A., Johnston, J. A., Taub, D. D., Xu, L., Michiel, D., Sprenger, H., Oppenheim, J. J., Kelvin, D. J. (1995) Granulocyte-colony stimulating factor and lipopolysaccharide regulate the expression of interleukin 8 receptors on polymorphonuclear leukocytes. J. Biol. Chem. 270, 28188-28192.
61. Khandaker, M., Xu, L., Rahimpour, R., Mitchell, G., DeVries, M. E., Pickering, J. G., Singhal, S. K., Feldman, R. D., Kelvin, D. J. (1998) CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. J. Immunol. 161, 1930-1938.
62. Xu, L., Rahimpour, R., Ran, L., Kong, C., Biragyn, A., Andrews, J., Devries, M., Wang, J. M., Kelvin, D. J. (1997) Regulation of CCR2 chemokine receptor mRNA stability. J. Leukoc. Biol. 62, 653-660.
63. Brazil, T. J., Rossi, A. G., Haslett, C., McGorum, B., Dixon, P. M., Chilvers, E. R. (1998) Priming induces functional coupling of N-formyl methionyl-leucyl-phenylalanine receptors in equine neutrophils. J. Leukoc. Biol. 63, 380-388.
64. Norgauer, J., Eberle, M., Fay, S. P., Lemke, H. D., Sklar, L. A. (1991) Kinetics of N-formyl peptide receptor up-regulation during stimulation in human neutrophils. J. Immunol. 146, 975-980.
65. Karlsson, A., Markfjäll, M., Strömberg, N., Dahlgren, C. (1995) Escherichia coli-induced activation of neutrophil NADH-oxidase: lipopolysaccharide and formylated peptides act synergistically to induce release of reactive oxygen metabolites. Infect. Immun. 63, 4606-4612.
66. Goldman, D. W., Enkel, H., Gifford, L. A., Chenoweth, D. E., Rosenbaum, J. T. (1986) Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonnuclear leukocytes. J. Immunol. 137, 1971-1976.
67. Katona, I. M., Ohura, K., Allen, J. B., Walh, L. M., Chenoweth, D. E., Wahl, S. M. (1991) Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators. J. Immunol. 146, 708-714.
68. Sozzani, S., Ghezzi, S., Iannolo, G., Luini, W., Borsatti, A., Polentaruti, N., Sica, A., Locati, M., Mackay, C., Wells, T. N., Biswas, P., Vicenzi, E., Poli, G., Mantovani, A. (1998) Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J. Exp. Med. 187, 439-444.
69. Cui, Y-H., Le, Y., Zhang, X., Gong, W., Abe, K., Sun, R., Van Damme, J., Proost, P., Wang, J. M. (2002) Up-regulation of formyl peptide receptor 2 (FPR2) in murine microglial cells by TNFα. Neurobiol. Dis., in press.
70. Lacroix, S., Feinstein, D., Rivest, S. (1998) The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol. 8, 625-640.
71. Stalder, M., Phinney, A., Probst, A., Sommer, B., Staufenbiel, M., Jucker, M. (1999) Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 154, 1673-1684.
72. Mackenzie, I. R., Hao, C., Munoz, D. G. (1995) Role of microglia in senile plaque formation. Neurobiol. Aging. 16, 797-804.
73. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P. A., Waridel, C., Calhoun, M. E., Jucker, M., Probst, A., Staufenbiel, M., Sommer, B. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13287-13292.
74. Mills, J., Reiner, P. B. (1999) Regulation of amyloid precursor protein cleavage. J. Neurochem. 72, 443-460.
75. Paresce, D. M., Ghosh, R. N., Maxfield, F. R. (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17, 553-565.
76. Seo, J. K., Bae, Y. S., Song, H., Baek, S. H., Kim, B. S., Choi, W. S., Suh, P. G., Ryu, S. H. (1998) Distribution of the receptor for a novel peptide stimulating phosphoinositide hydrolysis in human leukocytes. Clin. Biochem. 31, 137-141.
77. Le, Y., Gong, W., Li, B., Dunlop, N. M., Shen, W., Su, S. B., Ye, R. D., Wang, J. M. (1999) Utilization of two seven-transmembrane, G proteincoupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMV m for human phagocyte activation. J. Immunol. 163, 6777-6784.
78. Yazawa, H., Yu, Z. X., Takeda, K., Le, Y., Gong, W., Ferrans, V. J., Oppenheim, J. J., Li, C. C., Wang, J. M. (2001) Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J. 15, 2454-2462.
79. Shaffer, L. M, Dority, M. D., Gupta-Bansal, R., Frederickson, R. C., Younkin, S. G., Brunden, K. R. (1995) Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol. Aging 16, 737-745.
80. Chung, H., Brazil, M. I., Soe, T. T., Maxfield, F. R. (1999) Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by, microglial cells. J. Biol. Chem. 274, 32301-32308.
81. Weltzien, R. B., Pachter, J. S. (2000) Visualization of beta-amyloid peptide (Abeta) phagocytosis by human mononuclear phagocytes: dependency on Abeta aggregate size. J. Neurosci. Res. 59, 522-527.
82. DeWitt, D. A., Perry, G., Cohen, M., Doller, C., Silver, J. (1998) Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149, 329-340.
83. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., Seubert, P. (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177.
84. Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., Kang, D. E., Marquez-Sterling, N., Golde, T. E., Koo, E. H. (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414, 212-216.
85. McGettigan, P., Henry, D. (2000) Current problems with non-specific COX inhibitors. Curr. Pharm. Des. 6, 1693-1724.